Clinical trial
Neurobiology of Opioid Dependence: 2 - 2
NCT00000193 · Yale University, Other · Withdrawn
Key facts
| NCT number | NCT00000193 |
|---|---|
| Title | Neurobiology of Opioid Dependence: 2 - 2 |
| Official title | Neurobiology of Opioid Dependence: 2 |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Gamma hydroxybutyric |
| Enrollment | 0 |
| Start date | Jan 1, 1993 |
| Primary completion | Jan 1, 1998 |
| Completion | Jan 1, 1998 |
| First posted | Sep 21, 1999 |
| Last update posted | Aug 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: